| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 18 | 2025 | 514 | 2.590 |
Why?
|
| Exotropia | 5 | 2023 | 18 | 1.940 |
Why?
|
| MicroRNAs | 12 | 2024 | 949 | 1.850 |
Why?
|
| Cell Line, Tumor | 41 | 2025 | 3800 | 1.810 |
Why?
|
| Hepatitis B virus | 4 | 2024 | 142 | 1.800 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2025 | 353 | 1.730 |
Why?
|
| Phosphoprotein Phosphatases | 12 | 2021 | 127 | 1.700 |
Why?
|
| Strabismus | 3 | 2023 | 55 | 1.630 |
Why?
|
| Signal Transduction | 34 | 2025 | 4939 | 1.620 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 99 | 1.540 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1721 | 1.400 |
Why?
|
| Cell Movement | 11 | 2025 | 920 | 1.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2025 | 2137 | 1.280 |
Why?
|
| Cell Proliferation | 20 | 2025 | 2564 | 1.250 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 1626 | 1.200 |
Why?
|
| Lung Neoplasms | 10 | 2025 | 1783 | 1.140 |
Why?
|
| Hepatitis B | 4 | 2024 | 173 | 1.120 |
Why?
|
| Myocytes, Cardiac | 4 | 2024 | 663 | 1.100 |
Why?
|
| MAP Kinase Signaling System | 5 | 2021 | 324 | 1.100 |
Why?
|
| Apoptosis | 16 | 2025 | 1945 | 1.090 |
Why?
|
| Esotropia | 3 | 2022 | 14 | 1.060 |
Why?
|
| Receptors, Androgen | 5 | 2023 | 434 | 1.030 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 131 | 1.030 |
Why?
|
| RNA Helicases | 3 | 2022 | 73 | 1.000 |
Why?
|
| Macrophages | 5 | 2024 | 710 | 0.980 |
Why?
|
| Liver Neoplasms | 4 | 2025 | 1416 | 0.980 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 248 | 0.920 |
Why?
|
| Photosensitizing Agents | 1 | 2025 | 39 | 0.900 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2025 | 39 | 0.900 |
Why?
|
| Chaperonin 60 | 1 | 2024 | 31 | 0.870 |
Why?
|
| Exosomes | 1 | 2024 | 57 | 0.870 |
Why?
|
| Antineoplastic Agents | 9 | 2025 | 1854 | 0.870 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2025 | 266 | 0.850 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2020 | 125 | 0.820 |
Why?
|
| Hepatocytes | 8 | 2021 | 245 | 0.810 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2024 | 150 | 0.800 |
Why?
|
| Mice | 39 | 2025 | 19049 | 0.800 |
Why?
|
| Viral Proteins | 2 | 2015 | 360 | 0.790 |
Why?
|
| TOR Serine-Threonine Kinases | 12 | 2025 | 456 | 0.790 |
Why?
|
| Interleukin-8 | 4 | 2020 | 220 | 0.780 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 47 | 0.780 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 154 | 0.750 |
Why?
|
| Humans | 100 | 2025 | 134225 | 0.740 |
Why?
|
| Machine Learning | 2 | 2025 | 344 | 0.740 |
Why?
|
| PAX6 Transcription Factor | 1 | 2021 | 39 | 0.730 |
Why?
|
| NF-kappa B | 4 | 2025 | 483 | 0.730 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.730 |
Why?
|
| Tongue Neoplasms | 1 | 2021 | 30 | 0.720 |
Why?
|
| Animals | 50 | 2025 | 36526 | 0.710 |
Why?
|
| Diterpenes | 1 | 2019 | 29 | 0.640 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 393 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-ret | 5 | 2024 | 36 | 0.640 |
Why?
|
| Tumor Microenvironment | 7 | 2025 | 700 | 0.640 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2019 | 31 | 0.630 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 652 | 0.610 |
Why?
|
| Liver Failure, Acute | 2 | 2020 | 96 | 0.590 |
Why?
|
| China | 7 | 2023 | 296 | 0.580 |
Why?
|
| Colonic Neoplasms | 3 | 2024 | 271 | 0.570 |
Why?
|
| Neoplasms | 5 | 2023 | 3036 | 0.560 |
Why?
|
| Epithelial Cells | 2 | 2019 | 937 | 0.550 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 1006 | 0.540 |
Why?
|
| Atherosclerosis | 2 | 2024 | 1003 | 0.540 |
Why?
|
| Carcinogenesis | 2 | 2023 | 363 | 0.540 |
Why?
|
| Heart Failure | 3 | 2024 | 2440 | 0.530 |
Why?
|
| Retinitis Pigmentosa | 2 | 2014 | 97 | 0.520 |
Why?
|
| Reactive Oxygen Species | 8 | 2025 | 532 | 0.520 |
Why?
|
| Commiphora | 2 | 2013 | 2 | 0.520 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 2669 | 0.510 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 130 | 0.510 |
Why?
|
| Cause of Death | 1 | 2019 | 506 | 0.510 |
Why?
|
| Mutation | 7 | 2023 | 6350 | 0.510 |
Why?
|
| End Stage Liver Disease | 1 | 2019 | 202 | 0.500 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2024 | 701 | 0.490 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2024 | 612 | 0.490 |
Why?
|
| Smad Proteins | 1 | 2016 | 43 | 0.490 |
Why?
|
| Phosphorylation | 16 | 2016 | 1715 | 0.480 |
Why?
|
| Acetone | 1 | 2015 | 3 | 0.480 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 3 | 0.480 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 983 | 0.470 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 867 | 0.470 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 109 | 0.470 |
Why?
|
| Oxidative Stress | 2 | 2020 | 874 | 0.470 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 54 | 0.460 |
Why?
|
| DNA, Viral | 2 | 2016 | 500 | 0.450 |
Why?
|
| Androgen Antagonists | 4 | 2023 | 135 | 0.440 |
Why?
|
| Doxorubicin | 3 | 2025 | 303 | 0.440 |
Why?
|
| Mice, Nude | 7 | 2025 | 780 | 0.420 |
Why?
|
| Triterpenes | 1 | 2013 | 25 | 0.420 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2013 | 38 | 0.420 |
Why?
|
| Flavonoids | 3 | 2025 | 87 | 0.410 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 111 | 0.400 |
Why?
|
| RNA Interference | 8 | 2020 | 549 | 0.400 |
Why?
|
| cdc25 Phosphatases | 1 | 2012 | 20 | 0.390 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2025 | 1013 | 0.380 |
Why?
|
| HEK293 Cells | 5 | 2021 | 825 | 0.380 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 1885 | 0.380 |
Why?
|
| Male | 36 | 2025 | 66215 | 0.380 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 90 | 0.380 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2022 | 262 | 0.370 |
Why?
|
| Prognosis | 8 | 2025 | 5085 | 0.370 |
Why?
|
| T-Box Domain Proteins | 2 | 2015 | 124 | 0.370 |
Why?
|
| Registries | 1 | 2019 | 1588 | 0.370 |
Why?
|
| Interleukin-6 | 6 | 2024 | 450 | 0.370 |
Why?
|
| Lung | 1 | 2019 | 1578 | 0.370 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2022 | 249 | 0.360 |
Why?
|
| Osteoporosis | 2 | 2022 | 141 | 0.350 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 869 | 0.340 |
Why?
|
| Breast Neoplasms | 6 | 2025 | 2771 | 0.340 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 277 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 645 | 0.330 |
Why?
|
| Phenotype | 5 | 2024 | 4611 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2023 | 212 | 0.320 |
Why?
|
| Computational Biology | 3 | 2025 | 890 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 13 | 2024 | 4883 | 0.310 |
Why?
|
| Cell Line | 13 | 2018 | 2866 | 0.310 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 623 | 0.310 |
Why?
|
| Liver | 6 | 2020 | 1876 | 0.310 |
Why?
|
| Pyridones | 3 | 2016 | 130 | 0.300 |
Why?
|
| Transanal Endoscopic Surgery | 2 | 2018 | 3 | 0.300 |
Why?
|
| Cell Culture Techniques | 2 | 2023 | 295 | 0.300 |
Why?
|
| Mitochondria | 2 | 2024 | 759 | 0.300 |
Why?
|
| Blotting, Western | 10 | 2015 | 1138 | 0.290 |
Why?
|
| DNA Mutational Analysis | 3 | 2015 | 843 | 0.290 |
Why?
|
| Gene Expression | 6 | 2023 | 1622 | 0.280 |
Why?
|
| Sodium Compounds | 2 | 2019 | 9 | 0.280 |
Why?
|
| Arsenites | 2 | 2019 | 19 | 0.280 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 478 | 0.280 |
Why?
|
| Gluconeogenesis | 2 | 2018 | 111 | 0.280 |
Why?
|
| Rectal Neoplasms | 2 | 2018 | 81 | 0.270 |
Why?
|
| Female | 28 | 2025 | 72054 | 0.270 |
Why?
|
| Vision, Binocular | 3 | 2022 | 29 | 0.270 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 519 | 0.260 |
Why?
|
| Chronic Disease | 2 | 2023 | 1251 | 0.250 |
Why?
|
| Molecular Chaperones | 2 | 2024 | 174 | 0.250 |
Why?
|
| Oculomotor Muscles | 3 | 2022 | 68 | 0.250 |
Why?
|
| RNA Polymerase II | 2 | 2025 | 102 | 0.250 |
Why?
|
| RNA, Messenger | 4 | 2024 | 2915 | 0.240 |
Why?
|
| Cardiotoxicity | 2 | 2017 | 38 | 0.240 |
Why?
|
| Cell Differentiation | 5 | 2023 | 2044 | 0.240 |
Why?
|
| Flavanones | 1 | 2025 | 8 | 0.240 |
Why?
|
| Rhinitis, Allergic | 1 | 2025 | 15 | 0.240 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2025 | 39 | 0.240 |
Why?
|
| Pyroptosis | 1 | 2025 | 27 | 0.240 |
Why?
|
| Versicans | 1 | 2025 | 16 | 0.240 |
Why?
|
| Nanocomposites | 1 | 2025 | 6 | 0.240 |
Why?
|
| Tensins | 1 | 2025 | 3 | 0.240 |
Why?
|
| Chlorophyllides | 1 | 2025 | 3 | 0.230 |
Why?
|
| Mice, SCID | 3 | 2022 | 615 | 0.230 |
Why?
|
| Graphite | 1 | 2025 | 14 | 0.230 |
Why?
|
| Androgens | 3 | 2023 | 300 | 0.230 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2025 | 29 | 0.230 |
Why?
|
| THP-1 Cells | 1 | 2024 | 25 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 1351 | 0.230 |
Why?
|
| Sirolimus | 3 | 2012 | 239 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2025 | 62 | 0.230 |
Why?
|
| Polysaccharides | 2 | 2017 | 152 | 0.230 |
Why?
|
| Gene Frequency | 3 | 2015 | 780 | 0.230 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 59 | 0.230 |
Why?
|
| Photochemotherapy | 1 | 2025 | 44 | 0.220 |
Why?
|
| Benzamides | 2 | 2023 | 126 | 0.220 |
Why?
|
| Gene Expression Profiling | 4 | 2025 | 1922 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 453 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 18 | 0.220 |
Why?
|
| Smad1 Protein | 2 | 2014 | 23 | 0.220 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2025 | 73 | 0.220 |
Why?
|
| Thioctic Acid | 1 | 2024 | 10 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2025 | 509 | 0.220 |
Why?
|
| Open Reading Frames | 2 | 2015 | 220 | 0.220 |
Why?
|
| Tissue Scaffolds | 1 | 2025 | 85 | 0.220 |
Why?
|
| Dynamins | 1 | 2024 | 44 | 0.220 |
Why?
|
| Butyric Acid | 1 | 2024 | 7 | 0.220 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 128 | 0.220 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2021 | 68 | 0.220 |
Why?
|
| Rhabdomyosarcoma | 3 | 2016 | 211 | 0.210 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 232 | 0.210 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 1 | 2023 | 11 | 0.210 |
Why?
|
| Enzyme Activation | 5 | 2019 | 651 | 0.210 |
Why?
|
| Histone Deacetylase 2 | 1 | 2023 | 16 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 55 | 0.210 |
Why?
|
| Transcriptome | 3 | 2025 | 1135 | 0.210 |
Why?
|
| Interleukin-4 | 1 | 2024 | 148 | 0.210 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.210 |
Why?
|
| Kallikreins | 2 | 2021 | 31 | 0.210 |
Why?
|
| Glutamine | 1 | 2025 | 222 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 1 | 2025 | 229 | 0.210 |
Why?
|
| PPAR gamma | 1 | 2024 | 89 | 0.210 |
Why?
|
| Interleukin-13 | 1 | 2024 | 100 | 0.210 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2023 | 43 | 0.200 |
Why?
|
| Neoplasm Metastasis | 3 | 2025 | 745 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 677 | 0.200 |
Why?
|
| Aconitate Hydratase | 1 | 2023 | 13 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 489 | 0.200 |
Why?
|
| Killer Cells, Natural | 1 | 2025 | 357 | 0.200 |
Why?
|
| Interferon-alpha | 1 | 2024 | 246 | 0.200 |
Why?
|
| Water | 1 | 2024 | 200 | 0.200 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2021 | 93 | 0.200 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 60 | 0.200 |
Why?
|
| Homeostasis | 2 | 2024 | 751 | 0.200 |
Why?
|
| Osteoporotic Fractures | 1 | 2022 | 30 | 0.190 |
Why?
|
| Smad3 Protein | 2 | 2013 | 59 | 0.190 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 721 | 0.190 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 256 | 0.190 |
Why?
|
| Mice, Knockout | 3 | 2024 | 4012 | 0.190 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 108 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2025 | 445 | 0.190 |
Why?
|
| Nanoparticles | 1 | 2025 | 289 | 0.190 |
Why?
|
| Cell Survival | 4 | 2025 | 890 | 0.190 |
Why?
|
| Arabidopsis | 1 | 2023 | 94 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 1434 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 275 | 0.190 |
Why?
|
| Cryptocarya | 1 | 2021 | 1 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2016 | 182 | 0.190 |
Why?
|
| Cell Cycle | 3 | 2013 | 625 | 0.190 |
Why?
|
| Isoquinolines | 1 | 2021 | 41 | 0.180 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2021 | 13 | 0.180 |
Why?
|
| Alkaloids | 1 | 2021 | 37 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2538 | 0.180 |
Why?
|
| Tongue | 1 | 2021 | 34 | 0.180 |
Why?
|
| Autophagy | 3 | 2020 | 431 | 0.180 |
Why?
|
| Young Adult | 9 | 2022 | 9963 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2022 | 82 | 0.180 |
Why?
|
| Nitrogen | 2 | 2014 | 148 | 0.180 |
Why?
|
| Eye | 1 | 2023 | 245 | 0.180 |
Why?
|
| Cadmium | 2 | 2011 | 31 | 0.180 |
Why?
|
| Insulin Resistance | 2 | 2017 | 700 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2021 | 53 | 0.180 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2020 | 4 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 417 | 0.170 |
Why?
|
| Wound Healing | 1 | 2025 | 489 | 0.170 |
Why?
|
| Lignans | 1 | 2020 | 7 | 0.170 |
Why?
|
| Retrospective Studies | 8 | 2022 | 17591 | 0.170 |
Why?
|
| Finasteride | 1 | 2020 | 20 | 0.170 |
Why?
|
| Lactams | 1 | 2020 | 21 | 0.170 |
Why?
|
| Neuropeptides | 1 | 2021 | 116 | 0.170 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 1881 | 0.170 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 469 | 0.170 |
Why?
|
| Anoikis | 2 | 2022 | 9 | 0.170 |
Why?
|
| Cyclin B1 | 1 | 2020 | 8 | 0.170 |
Why?
|
| Caspase 3 | 3 | 2020 | 141 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 1222 | 0.170 |
Why?
|
| Middle Aged | 11 | 2025 | 29430 | 0.170 |
Why?
|
| Protein Phosphatase 2C | 3 | 2016 | 60 | 0.170 |
Why?
|
| Genotype | 3 | 2016 | 2822 | 0.160 |
Why?
|
| Molecular Structure | 3 | 2021 | 318 | 0.160 |
Why?
|
| Child | 9 | 2023 | 25917 | 0.160 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 609 | 0.160 |
Why?
|
| Chemokine CCL20 | 1 | 2019 | 16 | 0.160 |
Why?
|
| Eye Proteins | 1 | 2021 | 234 | 0.160 |
Why?
|
| Immunoprecipitation | 3 | 2016 | 206 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2020 | 182 | 0.160 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 97 | 0.160 |
Why?
|
| Multiprotein Complexes | 3 | 2016 | 219 | 0.160 |
Why?
|
| Hypoxia | 1 | 2021 | 268 | 0.160 |
Why?
|
| Pedigree | 2 | 2021 | 1732 | 0.160 |
Why?
|
| Exome | 2 | 2014 | 1088 | 0.160 |
Why?
|
| Acute Disease | 2 | 2022 | 1190 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 377 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2019 | 149 | 0.150 |
Why?
|
| Survival Analysis | 3 | 2020 | 1595 | 0.150 |
Why?
|
| Child, Preschool | 7 | 2023 | 14897 | 0.150 |
Why?
|
| Liver Function Tests | 1 | 2019 | 106 | 0.150 |
Why?
|
| Intelligence | 1 | 2019 | 107 | 0.150 |
Why?
|
| Rats | 6 | 2025 | 3876 | 0.150 |
Why?
|
| Glycogen | 2 | 2015 | 65 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 1070 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2025 | 918 | 0.150 |
Why?
|
| Gene Products, env | 1 | 2018 | 17 | 0.150 |
Why?
|
| Confidence Intervals | 1 | 2019 | 300 | 0.150 |
Why?
|
| Quinazolines | 1 | 2019 | 185 | 0.140 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 39 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 589 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 223 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2019 | 331 | 0.140 |
Why?
|
| Indoles | 1 | 2019 | 204 | 0.140 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 76 | 0.140 |
Why?
|
| Age Distribution | 1 | 2019 | 445 | 0.140 |
Why?
|
| Transfection | 2 | 2017 | 1099 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 260 | 0.140 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2018 | 100 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2018 | 264 | 0.140 |
Why?
|
| Cytokines | 1 | 2024 | 1397 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 907 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2020 | 536 | 0.140 |
Why?
|
| Adolescent | 8 | 2023 | 20647 | 0.140 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 823 | 0.140 |
Why?
|
| Piperidines | 1 | 2019 | 240 | 0.130 |
Why?
|
| Heart Function Tests | 1 | 2017 | 57 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2024 | 1148 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 628 | 0.130 |
Why?
|
| Databases, Genetic | 2 | 2020 | 507 | 0.130 |
Why?
|
| Antioxidants | 1 | 2019 | 373 | 0.130 |
Why?
|
| RNA, Viral | 2 | 2016 | 563 | 0.130 |
Why?
|
| Asthma | 1 | 2024 | 812 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 71 | 0.130 |
Why?
|
| Retroviridae | 1 | 2017 | 198 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 186 | 0.130 |
Why?
|
| Macaca mulatta | 1 | 2018 | 513 | 0.130 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2025 | 173 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2021 | 948 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2019 | 787 | 0.130 |
Why?
|
| Glucose | 2 | 2018 | 926 | 0.130 |
Why?
|
| Down-Regulation | 5 | 2018 | 718 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2016 | 8 | 0.130 |
Why?
|
| Laparoscopy | 2 | 2018 | 520 | 0.130 |
Why?
|
| Receptors, CXCR5 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Neurons | 3 | 2011 | 2051 | 0.120 |
Why?
|
| Adult | 10 | 2025 | 31962 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2023 | 914 | 0.120 |
Why?
|
| Chemokine CXCL13 | 1 | 2015 | 5 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 2178 | 0.120 |
Why?
|
| Incidence | 3 | 2019 | 3424 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cytosol | 1 | 2016 | 168 | 0.120 |
Why?
|
| Ebolavirus | 1 | 2016 | 47 | 0.120 |
Why?
|
| Twist-Related Protein 1 | 1 | 2016 | 39 | 0.120 |
Why?
|
| Isoleucine-tRNA Ligase | 1 | 2015 | 1 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 142 | 0.120 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2015 | 24 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2025 | 5225 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 4 | 2025 | 400 | 0.120 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2015 | 77 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 59 | 0.120 |
Why?
|
| Leukocyte Common Antigens | 1 | 2015 | 93 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 385 | 0.120 |
Why?
|
| Urethane | 1 | 2015 | 6 | 0.120 |
Why?
|
| Codon, Terminator | 1 | 2015 | 27 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2023 | 13105 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 3119 | 0.120 |
Why?
|
| Glycogenolysis | 1 | 2015 | 10 | 0.120 |
Why?
|
| Endoderm | 1 | 2015 | 24 | 0.120 |
Why?
|
| Protein Binding | 3 | 2014 | 1861 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 520 | 0.120 |
Why?
|
| Activins | 1 | 2015 | 74 | 0.120 |
Why?
|
| Serine | 1 | 2016 | 185 | 0.120 |
Why?
|
| Cholestasis | 1 | 2017 | 157 | 0.120 |
Why?
|
| Curcumin | 1 | 2015 | 42 | 0.120 |
Why?
|
| Astragalus Plant | 1 | 2014 | 2 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 135 | 0.110 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 344 | 0.110 |
Why?
|
| Virus Replication | 1 | 2018 | 636 | 0.110 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2014 | 34 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 3 | 2025 | 1087 | 0.110 |
Why?
|
| Smad8 Protein | 1 | 2014 | 6 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2016 | 330 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 352 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 236 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2014 | 40 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 5466 | 0.110 |
Why?
|
| Smad5 Protein | 1 | 2014 | 22 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 986 | 0.110 |
Why?
|
| Peptides | 1 | 2018 | 864 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 108 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2016 | 273 | 0.110 |
Why?
|
| Plant Exudates | 1 | 2013 | 2 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 795 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 178 | 0.110 |
Why?
|
| Disease Progression | 2 | 2025 | 2265 | 0.110 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2013 | 7 | 0.110 |
Why?
|
| I-kappa B Kinase | 2 | 2016 | 62 | 0.110 |
Why?
|
| Artemisinins | 1 | 2013 | 11 | 0.110 |
Why?
|
| Binding Sites | 2 | 2019 | 1386 | 0.100 |
Why?
|
| DNA Damage | 2 | 2018 | 547 | 0.100 |
Why?
|
| Thioredoxins | 1 | 2013 | 26 | 0.100 |
Why?
|
| Amino Acid Motifs | 3 | 2020 | 212 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 73 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 739 | 0.100 |
Why?
|
| Survival Rate | 1 | 2019 | 2214 | 0.100 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2013 | 88 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2017 | 489 | 0.100 |
Why?
|
| Caspase 9 | 1 | 2013 | 76 | 0.100 |
Why?
|
| Genes, Reporter | 2 | 2011 | 399 | 0.100 |
Why?
|
| Zebrafish | 2 | 2016 | 422 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 137 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2014 | 314 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 598 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 39 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2017 | 392 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1621 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 805 | 0.100 |
Why?
|
| Phylogeny | 1 | 2015 | 781 | 0.100 |
Why?
|
| Nickel | 1 | 2012 | 24 | 0.100 |
Why?
|
| RNA | 1 | 2016 | 607 | 0.100 |
Why?
|
| Aged | 6 | 2025 | 21822 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1357 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 256 | 0.100 |
Why?
|
| Copper | 1 | 2012 | 75 | 0.090 |
Why?
|
| Prostate | 1 | 2014 | 449 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1333 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 244 | 0.090 |
Why?
|
| Ion Transport | 1 | 2011 | 54 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 719 | 0.090 |
Why?
|
| Cells, Cultured | 5 | 2017 | 3181 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2011 | 55 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 373 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 250 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 824 | 0.090 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 26 | 0.090 |
Why?
|
| Terpenes | 1 | 2011 | 30 | 0.090 |
Why?
|
| Pyrroles | 1 | 2012 | 187 | 0.090 |
Why?
|
| Phytotherapy | 1 | 2011 | 51 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1436 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 317 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 48 | 0.080 |
Why?
|
| Cholesterol | 1 | 2013 | 574 | 0.080 |
Why?
|
| Rats, Wistar | 1 | 2011 | 398 | 0.080 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 270 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 29 | 0.080 |
Why?
|
| Software | 1 | 2015 | 736 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 284 | 0.080 |
Why?
|
| Ion Channels | 1 | 2011 | 210 | 0.080 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 81 | 0.080 |
Why?
|
| Proteolysis | 2 | 2024 | 198 | 0.080 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2025 | 108 | 0.080 |
Why?
|
| Immunophenotyping | 2 | 2024 | 345 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 135 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 1724 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 173 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 131 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 832 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 117 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 480 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2019 | 3754 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 965 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 3509 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2011 | 691 | 0.070 |
Why?
|
| Phosphoproteins | 4 | 2013 | 458 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2024 | 750 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2012 | 541 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 547 | 0.070 |
Why?
|
| Rectum | 2 | 2018 | 113 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 573 | 0.070 |
Why?
|
| Phosphorus | 1 | 2008 | 61 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2013 | 557 | 0.070 |
Why?
|
| Soil | 1 | 2008 | 72 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 152 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 748 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2018 | 1317 | 0.060 |
Why?
|
| Mice, Obese | 2 | 2017 | 76 | 0.060 |
Why?
|
| Risk Factors | 5 | 2022 | 11196 | 0.060 |
Why?
|
| Hep G2 Cells | 2 | 2016 | 98 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 150 | 0.060 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 257 | 0.060 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2015 | 6 | 0.060 |
Why?
|
| Exhalation | 1 | 2025 | 12 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2016 | 93 | 0.060 |
Why?
|
| Base Sequence | 3 | 2017 | 3181 | 0.060 |
Why?
|
| Particle Size | 1 | 2025 | 148 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 92 | 0.060 |
Why?
|
| Nasal Mucosa | 1 | 2025 | 68 | 0.060 |
Why?
|
| Chitosan | 1 | 2025 | 32 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1144 | 0.060 |
Why?
|
| Drug Carriers | 1 | 2025 | 119 | 0.060 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2016 | 62 | 0.060 |
Why?
|
| Breath Tests | 1 | 2025 | 186 | 0.060 |
Why?
|
| Random Allocation | 2 | 2016 | 446 | 0.060 |
Why?
|
| Elastomers | 1 | 2024 | 3 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2011 | 2735 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 329 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2025 | 433 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2024 | 97 | 0.050 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2024 | 24 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1098 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2017 | 362 | 0.050 |
Why?
|
| Brassinosteroids | 1 | 2023 | 1 | 0.050 |
Why?
|
| Plant Growth Regulators | 1 | 2023 | 9 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 128 | 0.050 |
Why?
|
| Niacinamide | 1 | 2023 | 31 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 18 | 0.050 |
Why?
|
| Temperature | 1 | 2024 | 327 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2023 | 66 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2023 | 68 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 1109 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 830 | 0.050 |
Why?
|
| Radius | 1 | 2022 | 36 | 0.050 |
Why?
|
| Blood Cells | 1 | 2022 | 55 | 0.050 |
Why?
|
| Neoplasm, Residual | 1 | 2023 | 134 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 186 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 237 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 333 | 0.050 |
Why?
|
| Optical Rotation | 1 | 2021 | 1 | 0.050 |
Why?
|
| Glucosidases | 1 | 2021 | 3 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2016 | 607 | 0.050 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2021 | 5 | 0.050 |
Why?
|
| Skin | 1 | 2025 | 545 | 0.050 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2021 | 28 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 89 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 2449 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2023 | 345 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2018 | 3172 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2016 | 967 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2022 | 3678 | 0.040 |
Why?
|
| Dutasteride | 1 | 2020 | 4 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 356 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2010 | 21 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2023 | 725 | 0.040 |
Why?
|
| Chromones | 1 | 2020 | 26 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 47 | 0.040 |
Why?
|
| NADP | 1 | 2020 | 55 | 0.040 |
Why?
|
| PC12 Cells | 2 | 2010 | 28 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 57 | 0.040 |
Why?
|
| Morpholines | 1 | 2020 | 64 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 307 | 0.040 |
Why?
|
| Protective Agents | 1 | 2020 | 36 | 0.040 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2020 | 15 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 38 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2022 | 311 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2020 | 63 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 105 | 0.040 |
Why?
|
| Bone Density | 1 | 2022 | 377 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2020 | 65 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 239 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2019 | 63 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 181 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 65 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 63 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2020 | 152 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 728 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 136 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 231 | 0.040 |
Why?
|
| Laparoscopes | 1 | 2018 | 5 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2018 | 59 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 678 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2018 | 39 | 0.040 |
Why?
|
| Antagomirs | 1 | 2017 | 2 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 150 | 0.040 |
Why?
|
| Oligoribonucleotides | 1 | 2017 | 9 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2017 | 7 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 92 | 0.040 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2017 | 18 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 393 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 449 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 46 | 0.040 |
Why?
|
| Operative Time | 1 | 2018 | 189 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 840 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 709 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 158 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 99 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2017 | 20 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 400 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2017 | 24 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 64 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 360 | 0.030 |
Why?
|
| Sendai virus | 1 | 2016 | 4 | 0.030 |
Why?
|
| Sierra Leone | 1 | 2016 | 31 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 19 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2016 | 16 | 0.030 |
Why?
|
| Octoxynol | 1 | 2016 | 9 | 0.030 |
Why?
|
| Gene Order | 1 | 2016 | 82 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2016 | 62 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 397 | 0.030 |
Why?
|
| Metaphase | 1 | 2016 | 35 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 411 | 0.030 |
Why?
|
| Emmetropia | 1 | 2015 | 4 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 69 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 96 | 0.030 |
Why?
|
| Pyridazines | 1 | 2016 | 54 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7244 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2016 | 55 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 202 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 151 | 0.030 |
Why?
|
| Diplopia | 1 | 2015 | 38 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2015 | 80 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 4802 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 259 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2017 | 139 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 241 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 239 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2015 | 18 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 262 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2949 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 346 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 2016 | 86 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Pteridines | 1 | 2014 | 12 | 0.030 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 15 | 0.030 |
Why?
|
| Imidazoles | 1 | 2016 | 220 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 541 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2015 | 40 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 145 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 260 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2015 | 124 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Imines | 1 | 2014 | 10 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 403 | 0.030 |
Why?
|
| Cyclization | 1 | 2014 | 17 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 258 | 0.030 |
Why?
|
| Oxides | 1 | 2014 | 15 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 71 | 0.030 |
Why?
|
| Hydrogen | 1 | 2014 | 41 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 400 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2014 | 22 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 88 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1774 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 434 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 485 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 278 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 113 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 155 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 638 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 239 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 308 | 0.030 |
Why?
|
| Carbon | 1 | 2014 | 98 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 398 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 181 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 201 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 452 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 633 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 972 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 298 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 111 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2014 | 166 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2013 | 13 | 0.030 |
Why?
|
| Teichoic Acids | 1 | 2013 | 13 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 1041 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 319 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 68 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 1392 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 234 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 1303 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1764 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2012 | 119 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 139 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2014 | 305 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1070 | 0.020 |
Why?
|
| Time Factors | 2 | 2015 | 6595 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1260 | 0.020 |
Why?
|
| Proteomics | 1 | 2016 | 604 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1486 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2016 | 712 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 175 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1044 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1982 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1308 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 120 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 132 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2793 | 0.020 |
Why?
|
| Receptors, Somatomedin | 1 | 2010 | 24 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 319 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 315 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2010 | 35 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 32 | 0.020 |
Why?
|
| Family | 1 | 2014 | 597 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 69 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 47 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2010 | 33 | 0.020 |
Why?
|
| Androstadienes | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2010 | 52 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2171 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 86 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2010 | 14 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 65 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 67 | 0.020 |
Why?
|
| Cyclins | 1 | 2010 | 105 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3978 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2010 | 115 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 417 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 45 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 50 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2010 | 86 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 34 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2319 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2010 | 253 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1735 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 255 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 259 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 3056 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 60 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 407 | 0.020 |
Why?
|
| Diffusion | 1 | 2008 | 58 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 100 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 285 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1538 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2010 | 1075 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 3434 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2592 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 1100 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3869 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13263 | 0.010 |
Why?
|